CTOs on the Move

Optimus Ride

www.optimusride.com

 
Optimus Ride Inc. is a MIT spinoff company based in Boston, MA that develops self-driving technologies that enable efficient, sustainable, and equitable mobility systems. Optimus Ride combines over 30 years of interdisciplinary university research in self-driving technologies (DARPA Urban Challenge), electric vehicles (CityCar), and Mobility-on-Demand Systems. The team also has a decade of industrial and entrepreneurial experience that includes shared fleets and manufacturing robots. Our team is focused on the fastest path to market, in order to maximize the benefits of self-driving technologies for all. We have created a highly collaborative, hands-on, and open environment that is centrally located in ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Optimus Ride raised $18M on 11/02/2017

Similar Companies

Sionic Mobile

Midtown Atlanta-based Sionic Mobile, a cloud-based connected commerce company, reaches millions of consumers in their vehicles and through their favorite mobile apps. The Company operates the Mobile Rewards Marketplace® - a digital loyalty co-op where brick-and-mortar merchants deliver offers, perks and rewards to consumers and accept their loyalty currency as cash at the point of sale. App partners include top-tier loyalty programs in automotive, travel and other channels. The award-winning ION Commerce Engine® (ICE) and Company-owned, GeoSense® iBeacon network drives more frequent app usage for partners and increases foot traffic and incremental new revenue to merchants. Merchants pay a small marketing fee when customers pay with their mobile apps.

Spend Matters

Headquartered in Chicago, Spend Matters Network is home to B2B media sites in the US, UK, Europe and Mexico/Latin America, including flagships Spend Matters and MetalMiner. Spend Matters is the largest online source of procurement-focused research, commentary and technology coverage, while MetalMiner is the leading resource providing unique insight, analysis and tools for metal purchasing organizations. Through groundbreaking approachable content from independent authoritative voices, Spend Matters Network™ improves how individuals interact with their markets, unlocking opportunities, enabling creative and better decisions and creating lasting change

ChroMedX

ChroMedX Corp. is a medical technology company focused on the development of novel, handheld medical devices for diagnostic testing at the patient`s bedside. HemoPalm, the Company`s lead product is the only handheld blood analysis system which combines Blood Gases & Electrolytes with full CO-oximetry. It has a single-use cartridge/handheld reader format, providing the simplest, most rapid and accurate testing process for use in management of critical care patients. Current blood gas systems require purchase of a second device to carry out CO-oximetry measurements. In addition, HemoPalm has the ability to draw capillary blood directly from pin-prick sites into the cartridge, as an alternative to the commonly required, risk-associated arterial blood draws. ChroMedX Corp. technologies are protected by the Company`s issued and pending patents, covering blood/plasma/serum collection, and processing and analysis.

Homeis

Homeis was created to help people like us, who belong here and there, and feel that the Internet is undeserving them. We’ve witnessed how difficult it is for local foreign-born communities to digitally connect, share their culture, their local knowledge, and unique context.

Cannadips CBD

We`re on a mission to supply quality CBD in a way that is radical and effective. Cannadips CBD allows you to live in the moment and experience life without distractions and 100% Tobacco Free. Our pouch-in-mouth product provides one of the best CBD experiences available. We utilize a proprietary process that preserves the valuable terpene and flavonoid compounds found in our American grown hemp, which in turn increases CBD bio-availability and allows for quick mucosal absorption directly in the mouth.